Albemarle Specialties — Net Sales increased by 2.7% to $358.41M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.7%, from $321.01M to $358.41M. Over 4 years (FY 2021 to FY 2025), Specialties — Net Sales shows relatively stable performance with a -1.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher sales indicate strong market demand and effective pricing strategies for specialty products.
The total revenue generated by the Specialties segment from the sale of goods and services, net of returns, allowances,...
Standard revenue metric used across all manufacturing and specialty chemical peers.
alb_segment_specialties_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $356.05M | $356.05M | $356.05M | $446.15M | $466.88M | $441.93M | $404.64M | $418.78M | $371.30M | $352.72M | $339.62M | $316.07M | $334.60M | $342.38M | $332.94M | $321.01M | $351.56M | $344.96M | $348.90M | $358.41M |
| QoQ Change | — | +0.0% | +0.0% | +25.3% | +4.6% | -5.3% | -8.4% | +3.5% | -11.3% | -5.0% | -3.7% | -6.9% | +5.9% | +2.3% | -2.8% | -3.6% | +9.5% | -1.9% | +1.1% | +2.7% |
| YoY Change | — | — | — | — | +31.1% | +24.1% | +13.6% | -6.1% | -20.5% | -20.2% | -16.1% | -24.5% | -9.9% | -2.9% | -2.0% | +1.6% | +5.1% | +0.8% | +4.8% | +11.7% |